Digital Health Solutions in Biotechnology: Transforming Diagnostics and Patient Engagement

Abstract

The digitization of health solutions in biotechnology has begun changing diagnosis and consumer experiences by deploying intelligent applications, including artificial intelligence, big data analytics, wearables, and tele pharmacy. They include identifying diseases at an early stage, real-time health surveillance and the creation of disease management profiles based on genotypical and phenotypical variations and lifestyle factors, among other factors. Technology solutions help to address telemedicine, increase the availability of health services, and solve the problems of communication between the patient and the doctor in the regions that need it, including remote ones. Moreover, new technologies such as the blockchain guarantee the safe sharing of information or patient information and anonymity, and the twin and competent manufacturing help to enhance the drug's affiliation and synthesis. Digital health solutions remain a promising roadmap for achieving significant improvements in healthcare outcomes, fast advancement of biotechnological industry, as well as active patient engagement in the management of one's health while facing certain obstacles, including data protection and integration. Such a shift represents a developing world of enhanced, affordable, patient-centre health care delivery models.